will semaglutide make me lose muscle and loss: Hidden risk for plans and PBMs Ozempic Butt Explained: How To

researchers to launch clinical trial Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women

Choosing the right GLP-1 helps: Keep fasting sugars within range Reduce long-term metabolic strain

JAMA Intern Med

FDA-approved medication is non-negotiable for you

Am J Physiol Renal Physiol (2016) 310(2):F1237

These receptor agonists are recognized for their cardioprotective properties and have been approved by the FDA to lower the risk of major adverse cardiovascular events in individuals who are overweight or obese with cardiovascular disease